SCHEMBL5378191

SCHEMBL5378191

OCCC=Cc1nn(Cc2ccc(F)cc2Cl)c2cc(OC(F)(F)F)ccc12

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
F2RL3 Q96RI0 8/20 0.38
ENPP2 Q13822 1/20 0.37
NR1H2 P55055 2/20 0.37
NR1H3 Q13133 2/20 0.37
NR1I2 O75469 1/20 0.37
NR3C1 P04150 1/20 0.37
AR P10275 1/20 0.37
RXRA P19793 1/20 0.37
PPM1A P35813 1/20 0.37
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2D6 P10635 1/20 0.36
TP53 P04637 3/20 0.35
MAPT P10636 2/20 0.35
GRM2 Q14416 1/20 0.34
P2RX7 Q99572 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5378187 1.00 F2RL3 (0.38) F2RL3ENPP2NR1H2NR1H3NR1I2
SCHEMBL5333744 0.95 F2RL3 (0.37) F2RL3ENPP2NR1H2NR1H3NR1I2
SCHEMBL5333741 0.95 F2RL3 (0.37) F2RL3ENPP2NR1H2NR1H3NR1I2
SCHEMBL5348946 0.92 CYP1A2 (0.39) F2RL3ENPP2CYP1A2CYP3A4CYP2C9
SCHEMBL5348942 0.92 CYP1A2 (0.39) F2RL3ENPP2CYP1A2CYP3A4CYP2C9
SCHEMBL5336985 0.91 F2RL3 (0.43) F2RL3ENPP2PPM1ACYP1A2CYP3A4
SCHEMBL5336983 0.91 F2RL3 (0.43) F2RL3ENPP2PPM1ACYP1A2CYP3A4
SCHEMBL5380651 0.87 ENPP2 (0.39) F2RL3ENPP2NR1H2NR1H3CYP2C9
SCHEMBL5380645 0.87 ENPP2 (0.39) F2RL3ENPP2NR1H2NR1H3CYP2C9
SCHEMBL5359999 0.86 NPSR1 (0.38) F2RL3ENPP2CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed